Status:
ACTIVE_NOT_RECRUITING
SMART-EST(Specialized Multi-center Attributed Registry of sTroke - EndovaScular or Thrombolytic Therapy)
Lead Sponsor:
Yonsei University
Conditions:
Ischemic Stroke
Eligibility:
All Genders
20-100 years
Brief Summary
Use of intravenous(IV) thrombolysis and intra-arterial(IA) recanalization treatment has been rapidly increasing, However, despite of the treatment, recanalization rates are 22.6 - 70% and only 30-50% ...
Detailed Description
1)Full design 1. The study proceeds with a parallel design of retrospective and prospective research. 2. As in the retrospective study, this study aims to establish the ideal screening criteria and t...
Eligibility Criteria
Inclusion
- Age ≥20 years old
- Acute ischemic stroke patients who underwent CT angiographies before IV thrombolysis and/or IA recanalization treatment
- Patients who give an informed consents for participation in the study or the legal representative or immediate family give informed consent on behalf of patients in case of difficulty to decide study enrollment.
Exclusion
- Age \<20 years old
- Acute ischemic stroke patients who did not receive IV thrombolysis and/or IA recanalization treatment
- No informed consents from patients
Key Trial Info
Start Date :
July 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2029
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04066556
Start Date
July 12 2019
End Date
June 1 2029
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, Yonsei University College of Medicine
Seoul, South Korea